Dr. Ascheim is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5 E 98th St
3rd Floor
New York, NY 10029Phone+1 212-427-1540Fax+1 212-410-7196
Education & Training
- New York Presbyterian Hospital(Cornell Campus)/Coney Island HospitalFellowship, Cardiovascular Disease, 1993 - 1996
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1990 - 1993
- New York University School of MedicineClass of 1990
Certifications & Licensure
- NY State Medical License 1992 - 2025
- CA State Medical License 2015 - 2024
Clinical Trials
- Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Heart Function in People Receiving an LVAD Start of enrollment: 2009 Aug 01
- Hybrid Revascularization Observational Study Start of enrollment: 2010 May 01
- The Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in Patients Undergoing LVAD Implantation Start of enrollment: 2012 Apr 01
Publications & Presentations
PubMed
- 198 citationsClinical outcomes for continuous-flow left ventricular assist device patients stratified by pre-operative INTERMACS classificationAndrew J. Boyle, Deborah D. Ascheim, Mark J. Russo, Robert L. Kormos, Ranjit John
The Journal of Heart and Lung Transplantation. 2011-04-01 - 775 citations2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association ...Patrick T O'Gara, Frederick G Kushner, Deborah D Ascheim, Donald E Casey Jr, Mina K Chung
Circulation. 2013-01-29 - 286 citationsSurgical Ablation of Atrial Fibrillation during Mitral-Valve SurgeryA. Marc Gillinov, Annetine C. Gelijns, Michael K. Parides, Joseph J. DeRose, Alan J. Moskowitz
The New England Journal of Medicine. 2015-04-08
Press Mentions
- CIRM $4 Million Awarded to Support Innovative Gene Therapy for Rare Heart DisorderSeptember 16th, 2024
- Rejuvenate Bio Appoints Deborah Ascheim, M.D., as Chief Medical OfficerJanuary 3rd, 2023
- Genentech Alum Jane Grogan Goes Startup Hopping from ArsenalBio to Graphite Bio; Scott Holmes to Handle CFO Duties at Catamaran Bio, Teaming up Again with Ex-Disarm CEOApril 30th, 2021
Committees
- member, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: